Download PDF
Facial Plast Surg 2009; 25(5): 324-328
DOI: 10.1055/s-0029-1243081
© Thieme Medical Publishers

Complications of Hyaluronic Acid Fillers

Michael J. Weinberg1 , Nowell Solish2
  • 1The Mississauga Cosmetic Surgery and Laser Clinic, Mississauga, Ontario, Canada
  • 2Women's College Hospital, University of Toronto, New Women's College Hospital, Toronto, Ontario, Canada
Further Information

Publication History

Publication Date:
18 December 2009 (online)

    Permissions and Reprints

ABSTRACT

Hyaluronic acid filler use, user groups, and indications have expanded significantly in the past several years. This group of fillers is extremely safe in experienced hands. Complications are infrequent but can be devastating. There can be no substitution for recognized and specific training. Prompt recognition and proper treatment of serious complication can moderate and even prevent serious sequelae. This article describes the most frequent and serious complications, their prevention, and treatment.

KEYWORDS

Hyaluronic acid complications - dermal fillers - hyaluronidase

REFERENCES

  • 1 Matarasso S L, Carruthers J D, Jewell M L. Restylane Consensus Group . Consensus recommendations for soft-tissue augmentation with nonanimal stabilized hyaluronic acid (Restylane).  Plast Reconstr Surg. 2006;  117(3 Suppl) 3S-34S
    PubMedGoogle Scholar
  • 2 McCracken M S, Khan J A, Wulc A E et al.. Hyaluronic acid gel (Restylane) filler for facial rhytids: lessons learned from American Society of Ophthalmic Plastic and Reconstructive Surgery member treatment of 286 patients.  Ophthal Plast Reconstr Surg. 2006;  22 188-191
    CrossrefPubMedGoogle Scholar
  • 3 Lemperle G. Avoidance and treatment of complications after dermal filler injections. In: Cohen SR, Born TM Facial Rejuvenation with Fillers. Maryland Heights, MO; Saunders Elsevier 2009: 135-154
    PubMedGoogle Scholar
  • 4 Glogau R G, Kane M A. Effect of injection techniques on the rate of local adverse events in patients implanted with nonanimal hyaluronic acid gel dermal fillers.  Dermatol Surg. 2008;  34(Suppl 1) S105-S109
    CrossrefPubMedGoogle Scholar
  • 5 Gladstone H B, Cohen J L. Adverse effects when injecting facial fillers.  Semin Cutan Med Surg. 2007;  26 34-39
    Google Scholar
  • 6 Bertucci V. Injectable filler complications. In: Beer K, Roberts W, Narurkar U, Lupo M Cosmetic Bootcamp Primer. London, UK; Informa Publishing 2010
    PubMedGoogle Scholar
  • 7 DeLorenzi C, Weinberg M, Solish N, Swift A. Multicenter study of the efficacy and safety of subcutaneous non-animal-stabilized hyaluronic acid in aesthetic facial contouring: interim report.  Dermatol Surg. 2006;  32 205-211
    CrossrefPubMedGoogle Scholar
  • 8 Pierre A, Levy P M. Hyaluronidase offers an effiacious treatment for inaesthetic hyaluronic acid overcorrection.  J Cosmet Dermatol. 2007;  6 159-162
    CrossrefPubMedGoogle Scholar
  • 9 Hirsch R J, Brody H J, Carruthers J DA. Hyaluronidase in the office: a necessity for every dermasurgeon that injects hyaluronic acid.  J Cosmet Laser Ther. 2007;  9 182-185
    CrossrefPubMedGoogle Scholar
  • 10 Alam M, Gladstone H, Kramer E M American Society for Dermatologic Surgery et al. ASDS guidelines of care: injectable fillers.  Dermatol Surg. 2008;  34(Suppl 1) S115-S148
    CrossrefPubMedGoogle Scholar
  • 11 Lemperle G, Gauthier-Hazan N, Wolters M, Eisemann-Klein M, Zimmermann U, Duffy D M. Foreign body granulomas after all injectable dermal fillers: part 1. Possible causes.  Plast Reconstr Surg. 2009;  123 1842-1863
    CrossrefPubMedGoogle Scholar
  • 12 Narins R S, Jewell M, Rubin M, Cohen J, Strobos J. Clinical conference: management of rare events following dermal fillers—focal necrosis and angry red bumps.  Dermatol Surg. 2006;  32 426-434
    CrossrefPubMedGoogle Scholar
  • 13 Friedman P M, Mafong E A, Kauvar A N, Geronemus R G. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation.  Dermatol Surg. 2002;  28 491-494
    CrossrefPubMedGoogle Scholar
  • 14 Inoue K, Sato K, Matsumoto D, Gonda K, Yoshimura K. Arterial embolization and skin necrosis of the nasal ala following injection of dermal fillers.  Plast Reconstr Surg. 2008;  121 127e-128e
    CrossrefPubMedGoogle Scholar
  • 15 Hirsch R J, Stier M. Complications of soft tissue augmentation.  J Drugs Dermatol. 2008;  7 841-845
    PubMedGoogle Scholar
  • 16 McCleve D E, Goldstein J C. Blindness secondary to injections in the nose, mouth, and face: cause and prevention.  Ear Nose Throat J. 1995;  74 182-188 , review
    PubMedGoogle Scholar
  • 17 Egidio J A, Arroyo R, Marcos A, Jimenez-Alfaro I. Middle cerebral artery embolism and unilateral visual loss after autologous fat injection into the galbellar area.  Stroke. 1993;  24 615-616
    PubMedGoogle Scholar
  • 18 Hanke C W, Higley H R, Jolivette D M, Swanson N A, Stegman S J. Abcess formation and local necrosis after treatment with Zyderm or Zyplast collagen implant.  J Am Acad Dermatol. 1991;  25 319-326
    CrossrefPubMedGoogle Scholar
  • 19 Woffles T L. Periorbital rejuvenation with injectable fillers. In: Cohen SR, Born TM Facial Rejuvenation with Fillers. Maryland Heights, MO; Saunders Elsevier 2009: 93-105
    PubMedGoogle Scholar

Michael J WeinbergB.Sc. M.Sc. M.D. F.R.C.S.C. 

The Mississauga Cosmetic Surgery and Laser Clinic

247 Queensway West, Mississauga, Ontario, Canada L5B 1B9

Email: drweinberg@mcsconline.com

      >